Earl Collier

Earl Collier

Director/Board Member chez CAPRICOR THERAPEUTICS, INC.

Fortune : 386 052 $ au 31/03/2024

76 ans
Health Technology
Commercial Services
Health Services

Profil

Earl M.
Collier
is currently the Chairman at Newton-Wellesley Hospital Corp.
He is also an Independent Director at Capricor Therapeutics, Inc., a Director at Codex Foundation, a Trustee at Boston Athenæum, an Advisor at InCube Venture Partners LLC, a Member at The Grolier Club of New York, and a Member at Book Club of California.
Previously, Mr. Collier held several positions including Chief Executive Officer & Director at deCODE genetics, Inc., Executive Chairman & Chief Executive Officer at Arsenal Medical, Inc., Chief Executive Officer & Director at Lyra Therapeutics, Inc., and Director at Capricor, Inc., Tesaro, Inc., TransMedics, Inc., Mass General Brigham, Inc., Encorium Group, Inc., and Gensight Biologics SA. He was also the President at VITAS Healthcare Corp.
and Partner at Hogan & Hartson LLP.
Additionally, he served as President at Genzyme Biosurgery Corp., Deputy Administrator at Centers for Medicare & Medicaid Services (US), and Deputy Administrator at US Department of Health & Human Services (DC).
Mr. Collier was also the Executive VP-Cardiovascular, Oncology & Genetics at Genzyme Corp.Mr. Collier completed his undergraduate studies at Yale University and obtained a graduate degree from the University of Virginia School of Law.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
23/04/2024 56 856 ( 0,18% ) 386 052 $ 31/03/2024

Postes actifs de Earl Collier

SociétésPosteDébut
CAPRICOR THERAPEUTICS, INC. Director/Board Member 20/11/2013
Codex Foundation Director/Board Member -
Book Club of California Corporate Officer/Principal -
The Grolier Club of New York Corporate Officer/Principal -
Director/Board Member -
Consultant / Advisor -
Chairman -
Tous les postes actifs de Earl Collier

Anciens postes connus de Earl Collier

SociétésPosteFin
GENSIGHT BIOLOGICS S.A. Director/Board Member 19/04/2017
Chief Executive Officer 01/01/2015
░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Earl Collier

Formation de Earl Collier

Yale University Undergraduate Degree
University of Virginia School of Law Graduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Earl Collier

Relations

100 +

Relations au 1er degré

24

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées3
LYRA THERAPEUTICS, INC.

Health Technology

GENSIGHT BIOLOGICS S.A.

Health Technology

CAPRICOR THERAPEUTICS, INC.

Health Technology

Entreprise privées19

Health Services

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Commercial Services

Commercial Services

Health Technology

Health Technology

Government

Health Services

Health Services

US Department of Health & Human Services (DC)

Government

Commercial Services

Finance

The Grolier Club of New York

Book Club of California

Codex Foundation

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Earl Collier